JULIA LOBRACE: Open Payments
NPI 1235908179 · WESTFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$401 in 23 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $387 · 2025 $401
Food & beverage: $401
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $87 |
| Lilly USA, LLC | 4 | $63 |
| ABBVIE INC. | 4 | $58 |
| Dexcom, Inc. | 3 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Hologic Sales and Service, LLC | 1 | $29 |
| Bausch Health US, LLC | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Exact Sciences Corporation | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
Products named: MOUNJARO, VRAYLAR, Wegovy, Dexcom G6 Transmitter, Kerendia, Ozempic, APTIMA, APLENZIN.
Industry payments across NJ — which companies pay providers there.
